Introduction
Gonococci are developing partial and total resistance to penicillin. In late 1975, P-lactamase-producing, or penicillinase-producing, Neisseria gonorrhoeae (PPNG) emerged and in the following years quickly found a foothold in certain African and Asian countries. There is thus a need to search for effective alternatives to penicillin in combating these gonococci. None of the alternative drugs listed by the World Health Organisation have the same advantages as penicillin, since some are costly, others toxic, or they may need to be given in multiple doses.' The cephalosporins were recognised early to have potential in treating gonorrhoea. However, they and their analogues gave poor treatment results.2A
Changes in the chemical structure of the cephalosporins have resulted in an increased antibacterial spectrum, more useful pharmacokinetic properties, and, in some cases, a high level of resistance to P-lactamase hydrolysis.
A second generation cephalosporin, HR 756, 7-2-(2-amino-4-thiazolyl)-2-(Z)-(methoximino) acetamidocephalosporanic acid (figure) has been found to have great P-lactamase stability. Pain at injection site. Two patients complained of severe pain for one hour and 11 of moderate pain for half to one hour. The others found little discomfort after injection. Local reactions. None was recorded. Systemic reactions. Two patients complained of fever and giddiness a few hours after injection and this lasted for about 12 hours. One patient complained of chills and rigor five hours after injection, which was followed by fever for one day. This particular patient was known to be hypersensitive to penicillin. Another patient complained of generalised skin irritation for one week but there was no obvious rash. Blood counts and biochemical tests. Blood counts, blood SGPT, and urea concentrations before and after treatment showed no significant change. Effect of concomitant medication. Sixteen female patients were taking oral contraceptives, five male prostitutes were taking oestrogen pills, and one male patient was taking antacids for gastric discomfort. All of them responded to treatment.
Discussion
The early cephalosporins were not very effective against N gonorrhoeae, but some of the newer ones, cephamandole, cefuroxime, and cefoxitin (cephamycin), are found to be effective against both PPNG and non-PPNG strains.8-'0 HR 756 is one of the second generation of cephalosporins which is highly effective against a wide variety of Gram-positive and Gram-negative bacteria, including N gonorrhoeae. '1-13 In the present study, the clinical response was very good. The overall cure rate was 97 * 05 % while that of PPNG and non-PPNG infections was 98-2o and 95-7%o respectively. These results are totally acceptable epidemiologically. Bacteriologically, it was found that all the strains were inhibited by 0 3 M.g/ml of the antibiotic. This is comparable to a previous study, in which 0-016 jAg/ml of the antibiotic inhibited 68 strains of PPNG and 69 strains of non-PPNG.'3 It has been reported that higher concentrations of HR 756 are needed to inhibit non-PPNG strains, which were less susceptible to penicillin. This is confirmed in the present study, in which the MICs of HR 756 correlated directly with those of penicillin.
In-vitro studies indicated that HR 756 was more potent in inhibiting N gonorrhoeae than other antibiotics, such as tetracyclines, cefamandole, and cefoxitin.14 The present in-vivo study seems to confirm this because of the good clinical response to only 500 mg of the drug in a single dose. The dosage of cefuroxime used by other workers was 2 g.9 10 None of the three patients who failed to respond to treatment carried strains which were resistant to the antibiotic; the MICs were 0 016, 0 008 and 0 008 jg/ml. Correlation of the MICs with treatment response shows that failure may be expected with the present regimen when the MIC is 0 008 Jg/ml or above. Further studies will be necessary to determine if this is so.
The overall tolerance to the drug was good. It is interesting to note that one of the patients who had a systemic reaction was originally hypersensitive to penicillin. This illustrates the possibility of crosssensitisation between penicillin and cephalosporins.
The drug did not affect the blood counts and biochemical tests in any of the patients. The dose may be too small for non-allergic toxic reactions to appear.
We conclude that the antibiotic, HR 756, is effective and safe, especially at the relatively low dosage of 500 mg. It is a good alternative to penicillini in the treatment of gonorrhoea because of its efficacy against the PPNG strains.
